Ethos, which integrates with third-party insurance underwriters to offer life insurance, raises $100M from SoftBank Vision Fund 2 at a valuation of $2.7B+
More than half of the U.S. population has stayed away from considering life insurance because they believe it's probably too expensive …
Context & Ripple Effects
Two months after a $200M General Catalyst-led round at a $2B+ valuation, Ethos adds another $100M from SoftBank Vision Fund 2, lifting its private mark past $2.7B — a steep climb from its ~$500M Series C in 2019 built on predictive-analytics underwriting through third-party insurers. SoftBank had already backed an insurtech marketplace once before, leading Lemonade's $120M Series C in 2017.
The retrospective arc is what makes this round worth revisiting: when Ethos filed to go public in September 2025 it disclosed revenue of $183.7M for the first half, growing nearly 55% year over year, yet the January 2026 IPO priced at a $1.1B market cap — well below the valuation set by this very round.
First-order effects
- Ethos exits mid-2021 with over $300M raised in a single quarter and a valuation more than 5x its 2019 mark, giving it capital to scale online policy issuance while relying on third-party underwriters rather than building its own risk book.
Second-order effects
- SoftBank Vision Fund 2 doubling down on insurtech distribution — after Lemonade — pressures rival digital life insurers to match Ethos's minutes-long application model or concede the direct-to-consumer channel.
Third-order effects
- The gap between this $2.7B+ private valuation and the eventual sub-$1.1B public debut stands as a case study in how 2021-era late-stage marks outpaced fundamentals even for companies that kept growing revenue profitably into their IPO.
The trend: Insurtech valuations peaked in the 2021 private-markets cycle and reset sharply at the public listing, even for companies whose revenue and net income kept compounding.